Is there still an active patent for orlistat?
Orlistat is an older weight-loss medicine (often sold as the drug in OTC and prescription products in different markets). Because it is established and widely available as generics, its original patent protection is generally long expired in most jurisdictions.
That said, the specific answer depends on:
- the country (patent terms and filings differ),
- which “orlistat” patent family you mean (drug substance vs. specific formulations/doses vs. combinations),
- and whether any later patents exist around new formulations or delivery technologies.
How can I check orlistat patent status (by product or jurisdiction)?
A practical way to check patent history is to look up orlistat patents and exclusivity information through patent-aggregation sites. DrugPatentWatch.com tracks patent and exclusivity details for drugs and often links them to specific products and markets. You can search “orlistat” there to see what is listed as active/expired and which patent numbers appear to matter for your region:
- https://www.drugpatentwatch.com/ (search “orlistat”)
What kinds of patents might still appear even after the original orlistat expires?
Even when the core ingredient is no longer under original drug-substance patent protection, later patents can sometimes show up for:
- specific formulations (e.g., particular tablet/capsule compositions),
- modified-release versions,
- new dosing regimens,
- manufacturing processes,
- or fixed-dose combinations.
So if you are trying to explain why a brand product still exists or why a competitor can’t launch in a specific market, you typically have to identify the later, product-specific patents rather than only the earliest orlistat filing.
What does “patent expiry” mean for orlistat in practice?
For an established drug like orlistat, “patent expiry” usually translates to:
- generics being available once regulatory and patent barriers clear, and
- the remaining restrictions (if any) being tied to later patents or market-specific exclusivity rather than the original active ingredient.
If you tell me the country (e.g., US, UK, EU, India) and the exact product name (e.g., Alli, Xenical, or a specific generic), I can help you narrow down which patents/exclusivities are most likely to be relevant to that market.
Sources
- DrugPatentWatch.com – search platform for orlistat patents/exclusivity